While colchicine and IL-1 antagonists are effective in AA amyloidosis associated with HPFS6–7; TNF inhibitors, IL-6 antagonists and other b-DMARDs are used in addition to cs-DMARDs in AA amyloidosis associated with RA and other inflammatory diseases for this purpose.8–9. Here, IL6 is linked to AA amyloidosis.